Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Role of 200 mg Versus 400mg Vaginal Progesterone in Prevention of Preterm Labor in Twin Gestation With Short Cervix: a Double-Blind Randomized Controlled Trial

NCT03781674 is registered in ClinicalTrials.gov with Aswan University Hospital as lead sponsor.

NCT NCT03781674
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03781674 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Role of 200 mg Versus 400mg Vaginal Progesterone in Prevention of Preterm Labor in Twin Gestation With Short Cervix: a Double-Blind Randomized Controlled Trial
Lead sponsor
Aswan University Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
January 1, 2019
Completion date
March 1, 2022
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

twin; pregnancy, affecting fetus or newborn